Delivery Order SPE2DB20D3103-SPE2DB22FN3G2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,292.56 firm-fixed-price delivery order is for the supply of 4,563,356 units of the drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,553.73 Firm Fixed Price Delivery Order contract covers the supply of 4,563,160,024 Escitalopram 5 mg tablets, with a period of performance through December 22, 2023. The contract was awarded on an unrestricted, full and open competition basis and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,443.36 for 4,555,215,681 units of the drug escitalopram 10 mg tablets. The contract was awarded on October 26, 2021 by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of October 27, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,443,699 units of the medication Escitalopram 10 mg tablets. The $1,612.80 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $14,921.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,554,378 units of Escitalopram 10 mg tablets, a medication used to treat mental health conditions. This is a firm-fixed price delivery order contract with an ultimate completion date of August 11, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Escitalopram 10 mg tablets. The $2,767.45 firm fixed-price contract has a completion date of September 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,230.49 firm fixed-price delivery order is for the supply of 4,559,292,364 units of escitalopram 10 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with a ceiling value of $999,999,999.00. The IDC, which runs...
- This federal contract award, with ID SPE2DX15D1053 | SPE2DX24F6BUZ, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,652.70 firm fixed-price delivery order is for the supply of 4,562,566,047 escitalopram 10 mg tablets. The contract has an ultimate completion date of October 24, 2023 and was awarded on October 23, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for 4,563,955,449 units of the medication Escitalopram 10 mg tablet. The contract has a total ceiling value of $10,658.61 and an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp, through its Corporate Office...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,635.38, is a delivery order for 4,562,280,822 units of the drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN3G2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,871,241 Escitalopram 10 mg tablets. The contract has a total ceiling value of $3,735.47 and is a firm fixed-price delivery order with an ultimate completion date of April 13, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 4/12/22 |